EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Transcriptome profiling and experimental validation identify FOS, RAC2, and TYROBP as potential biomarkers for Fu’s subcutaneous needling in neuropathic pain treatment

Huiqin Fang iD, Yaping Li iD, Jiaqi Li, Yarong Sun iD, Yunhua Zang iD

Molecular Pain · 2026-06 · 22

DOI: 10.1177/17448069261459255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pain, online erschienen am 03.06.2026. Verfasst von Huiqin Fang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao, Shandong, Chi…. Hauptthemen laut MEDLINE: Neuralgia, Biomarkers, Gene Expression Profiling, Acupuncture Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Shenzhen Municipal Science and Technology Program Project, the Traditional Chinese Medicine Research Project of Guangdong Provincial Administration of Traditional Chinese Medicine, the Medical and Health Research Project of Bao'an District Medical Association in Shenzhen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to explore potential biomarkers and mechanisms underlying in the treatment of neuropathic pain (NP) with Fu’s subcutaneous needling (FSN), employing a transcriptomics approach.

Methods

In this study, RNA sequencing was performed in a rat model of chronic constriction injury treated with FSN and acupuncture methods. The FSN-related genes in the treatment of NP with FSN were obtained by overlapping the results of differential expression analysis. Potential biomarkers were identified by protein-protein interaction (PPI) analysis and machine learning. In addition, potential biomarkers were analyzed for functional enrichment, molecular regulatory networks, and drug prediction. Reverse transcription quantitative PCR (RT-qPCR) was employed to validate the expression levels of the biomarkers.

Results

FOS, RAC2, and TYROBP were identified as potential biomarkers. Furthermore, mo-miR-92a-2-5p was predicted to co-target RAC2 and TYROBP. Twenty-five drugs were predicted to target FOS and four drugs were predicted to target RAC2 were also identified. FSN treatment enhanced and attenuated the expression of RAC2, TYROBP, and FOS, respectively.

Conclusion

In this study, FOS, RAC2, and TYROBP were identified as potential biomarkers in the treatment of NP with FSN, providing a potential theoretical basis for NP treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaBiomarkersGene Expression ProfilingAcupuncture TherapyProto-Oncogene Proteins c-fosrac GTP-Binding ProteinsAdaptor Proteins, Signal TransducingAnimalsRats, Sprague-DawleyMaleRAC2 GTP-Binding ProteinRatsProtein Interaction MapsMicroRNAsReproducibility of Results

Stichwörter der Autor:innen

Fu’s subcutaneous needlingNeuropathic painacupuncturebiomarkerstranscriptomics

Substanzen

BiomarkersProto-Oncogene Proteins c-fosRAC2 GTP-Binding Proteinrac GTP-Binding ProteinsAdaptor Proteins, Signal TransducingMicroRNAs

Autor:innen und Institutionen

  • Neurology Department, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), Qingdao, Shandong, China.
  • Encephalopathy Rehabilitation Department, Weifang Traditional Chinese Medicine Hospital, Weifang, Shandong, China.
  • General Medicine, Bao'an Authentic TCM Therapy Hospital, Shenzhen, Guangdong, China.
  • Institute of Integrated Medicine, Qingdao University, Qingdao, Shandong, China.
  • Clinical Division of the School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.

ORCID-Profile: Huiqin Fang, Yaping Li, Yarong Sun, Yunhua Zang

Förderung

  • the Shenzhen Municipal Science and Technology Program Project
  • the Traditional Chinese Medicine Research Project of Guangdong Provincial Administration of Traditional Chinese Medicine
  • the Medical and Health Research Project of Bao'an District Medical Association in Shenzhen

Zitieren

APA

Fang, H., Li, Y., Li, J., Sun, Y., & Zang, Y. (2026). Transcriptome profiling and experimental validation identify FOS, RAC2, and TYROBP as potential biomarkers for Fu’s subcutaneous needling in neuropathic pain treatment. Molecular Pain, 22. https://doi.org/10.1177/17448069261459255

Vancouver

Fang H, Li Y, Li J, Sun Y, Zang Y. Transcriptome profiling and experimental validation identify FOS, RAC2, and TYROBP as potential biomarkers for Fu’s subcutaneous needling in neuropathic pain treatment. Molecular Pain. 2026;22. doi:10.1177/17448069261459255

BibTeX
@article{Fang2026,
  author = {Fang, Huiqin and Li, Yaping and Li, Jiaqi and Sun, Yarong and Zang, Yunhua},
  title = {Transcriptome profiling and experimental validation identify FOS, RAC2, and TYROBP as potential biomarkers for Fu’s subcutaneous needling in neuropathic pain treatment},
  journal = {Molecular Pain},
  year = {2026},
  volume = {22},
  doi = {10.1177/17448069261459255}
}
Kostenlos starten →